GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

3 Months Ended

Jan. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segments during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January 31, 2018:

	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2017	$	818	$	1,285	$	504	$	2,607
Foreign currency translation impact	8		9		4		21
Goodwill arising from acquisitions	5		—		—		5
Goodwill as of January 31, 2018	$	831	$	1,294	$	508	$	2,633

Components of other intangibles during the period

The components of other intangible assets as of January 31, 2018 and October 31, 2017 are shown in the table below:

	Purchased Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2017
Purchased technology	$	855	$	646	$	209
Trademark/Tradename	149		73		76
Customer relationships	151		112		39
Third-party technology and licenses	27		14		13
Total amortizable intangible assets	1,182		845		337
In-Process R&D	24		—		24
Total	$	1,206	$	845	$	361
As of January 31, 2018
Purchased technology	$	863	$	665	$	198
Trademark/Tradename	149		76		73
Customer relationships	153		119		34
Third-party technology and licenses	27		16		11
Total amortizable intangible assets	1,192		876		316
In-Process R&D	25		—		25
Total	$	1,217	$	876	$	341

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2018 and for each of the five succeeding fiscal years and thereafter is estimated below:

Estimated future amortization expense:
(in millions)
Remainder of 2018	$	73
2019	$	71
2020	$	56
2021	$	42
2022	$	32
2023	$	21
Thereafter	$	21